Archive for August 10th, 2008

Buy Ipca Labs

Strong performance in branded finished dosages, growth momentum in exports and a strong position in anti-malarial drugs makes Ipca Labs, a medium sized pharma company with Rs 1,100 crore revenues, a good investment option.
At the current market price of Rs 567, the stock trades at 8 times its 2008-09 earnings per share; at a discount [...]


ss_blog_claim=6aa2ecd180820f4aa1e9ad184a46fb80